Quick answer: Published Semax work spans rat models of cerebral ischemia (permanent and transient occlusion), spinal cord injury, chronic and acute stress, and neonatal maternal deprivation. Each model supports different endpoints: transcriptomes and neurotrophin mRNA for ischemia, cytokine immunohistochemistry for spinal injury, behavior plus hippocampal markers for stress. Picking the model starts from the question, not the compound. Laboratory research use only.
Start from the question
Pages about Semax and neuroprotection in animal models tend to list models as if they were interchangeable. They are not. An occlusion model tests a different biology than a restraint-stress model, and the endpoints that make sense differ too. This guide is organized as a selection aid: given a research question, which published model fits, what has been measured in it, and where its limits lie. It complements the mechanism-oriented Semax research overview and the explainer what is Semax.
All of the work discussed is on rats. Nothing here is a statement about use outside a laboratory, and the amounts and routes belong to the papers cited. Semax is the heptapeptide Met-Glu-His-Phe-Pro-Gly-Pro; V8 Peptides supplies it as a 15 mg lyophilized research vial (stated purity at least 98% by HPLC), described on the Semax product page.
Model family 1: cerebral ischemia
Two occlusion models are used. In permanent middle cerebral artery occlusion (pMCAO) the vessel stays blocked; in transient occlusion (tMCAO) flow returns after a set time. Semax work in these models focuses on gene expression. After pMCAO, Semax and the tripeptide Pro-Gly-Pro both activated transcription of neurotrophins and their receptors in the cortex with partly overlapping profiles, Semax acting selectively at several time points between 3 and 72 hours [1]. After tMCAO, RNA-seq studies reported hundreds to thousands of differentially expressed genes depending on peptide, region and time, with both Semax and the comparator peptide ACTH(6-9)PGP partially reversing ischemia-induced changes in immune- and neurosignaling-related genes [2,3].
Best for: questions about transcriptional programs after injury, neuroimmune pathways, comparisons among peptide fragments. Limits: expression endpoints are indirect; surgical variability is high; time point choice changes the answer.
Model family 2: spinal cord injury
A rat model of acute spinal cord injury used laminectomy at the second thoracic vertebra with mild (20 g) or severe (35 g) aneurysm clips. Semax was applied intranasally to the exposure group and 0.9% NaCl to controls, with tissue collected at 3 and 6 hours and analyzed by immunohistochemistry for IL-4, IL-10 and IL-13 in the posterior horn. The abstract reports greater anti-inflammatory cytokine levels in the Semax group, more pronounced in mild compression at 3 hours, and notes that further work is needed to determine optimal parameters [4].
Best for: short-interval inflammatory readouts after mechanical injury. Limits: a 3- and 6-hour window captures only the very early cascade, antibody-based quantification is semi-quantitative, and no functional outcome is reported in the abstract.
Model family 3: chronic and acute stress
Stress models pair behavior with hippocampal biology. In a chronic unpredictable stress model in male Sprague-Dawley rats, daily intraperitoneal administration of a low amount of Semax (60 nmol/kg) or the melanocortin agonist Melanotan II reversed or substantially attenuated stress-induced anhedonia, suppression of body mass gain, adrenal hypertrophy and a fall in hippocampal BDNF [5]. In an acute restraint stress model, Semax at 100 µg/kg given 30 minutes before the stressor attenuated stress-induced behavioral alterations, and hippocampal RNA-seq at 4.5 hours showed more than 1,500 differentially expressed genes in Semax-exposed animals compared with fewer than 400 for ACTH(6-9)PGP, with about 250 shared genes shifting in the same direction [6].
Best for: questions linking behavior to hippocampal expression, comparing peptides in the same stress paradigm. Limits: behavioral tests are noisy, stress paradigms differ between labs, and most work uses males.
Model family 4: early-life stress
In neonatal maternal deprivation (5 hours a day during postnatal days 1 to 14), daily intranasal Semax at 0.05 mg/kg from postnatal days 15 to 28 weakened the impact of deprivation on body mass and normalized anxiety in one-month-old rats [7].
Best for: developmental questions with a long gap between exposure and readout. Limits: litter effects are large and demand careful statistics, and the paper is short.
Selection matrix
| Research question | Model that fits | Typical endpoint | Time window in the papers |
|---|---|---|---|
| Transcriptional response to ischemia | pMCAO or tMCAO | Neurotrophin mRNA, RNA-seq | 3 to 72 h (pMCAO); 4.5 and 24 h (tMCAO) |
| Peptide fragment comparison | tMCAO with comparator | DEG counts, immune and neurosignaling genes | 4.5 and 24 h |
| Early inflammatory cytokines after injury | Spinal cord clip injury | IL-4, IL-10, IL-13 immunohistochemistry | 3 and 6 h |
| Behavior and hippocampal BDNF | Chronic unpredictable stress | Sucrose preference, BDNF | Daily over weeks |
| Stress-induced expression | Acute restraint stress | Behavior, hippocampal RNA-seq | 30 min pre-exposure; 4.5 h |
| Developmental programming | Neonatal maternal deprivation | Body mass, anxiety-type behavior | Exposure days 15 to 28; testing at one month |
Practical differences that decide feasibility
| Factor | Ischemia | Spinal injury | Stress | Early-life |
|---|---|---|---|---|
| Surgery required | Yes | Yes | No | No |
| Typical sampling | Hours | Hours | Hours to weeks | Weeks |
| Main readouts | Omics | Immunohistochemistry | Behavior plus omics | Behavior |
| Biggest variance source | Lesion size | Clip force | Handling stress | Litter |
| Route in papers | Varied | Intranasal | Intraperitoneal or per paper | Intranasal |
Controls that every model needs
Regardless of model, four controls recur in well-run work. A vehicle group handled the same way, including restraint for intranasal application. A sham group for surgical models. A comparator where the question concerns the peptide's structure, such as Pro-Gly-Pro or ACTH(6-9)PGP, since several papers show these are not inert. And randomization with blinded scoring, because behavioral and histological scores are easily biased.
Stock arithmetic across models
The published amounts are written in µg/kg, mg/kg and nmol/kg, so conversions are routine. Stock concentration is vial mass divided by diluent volume. Amount per animal is the per-kilogram figure times body mass in kilograms. Volume is amount divided by stock concentration. To convert nmol/kg to µg/kg multiply by the molar mass (about 813.9 g/mol from the formula C37H51N9O10S) and divide by 1000. These are formulas, not recommendations; the reconstitution calculator handles the concentration step, and the volume calculation guide explains the rest. Record the lot, and check the COA page and the how to read a COA guide for what documentation to expect.
Reading a model paper critically
A few questions sharpen the reading of any model paper. What exactly was the control: saline, a comparator peptide, or sham surgery? How many animals were in each group, and how were they allocated? Was the person scoring behavior or histology blind to exposure? Was the time point chosen before the experiment or after looking at the data? Did the paper report all measured endpoints or only those that moved? None of these questions is specific to Semax, but the Semax literature is dominated by omics studies, where the number of measured genes is huge and group sizes are small, so multiple-testing correction and pre-specified thresholds carry more weight than usual.
Another useful habit is to write down, for each paper, the single sentence the data directly support. For the spinal injury paper it is: intranasal Semax was associated with higher IL-4, IL-10 and IL-13 immunostaining at 3 and 6 hours in the posterior horn of injured rats. For the chronic stress paper it is: daily intraperitoneal Semax or Melanotan II was associated with attenuation of the listed stress-induced changes. Sentences like these are narrower than headlines, and they are the right size for a methods section.
Combining models in one research program
Because each model answers a narrow question, a research program often chains them. A stress model can screen behavior and hippocampal markers cheaply before a surgical model is attempted. An expression screen in one model can nominate genes to test by qPCR in another. A comparator peptide run in several models shows whether a profile is consistent or model-specific. Chaining works only if the stock preparation, route and animal strain are documented tightly enough that results from different weeks can be compared, which is the reason the arithmetic and lot records above are worth the effort.
What the model literature does not establish
The models are rat models. Several papers come from the same groups, so independence is limited. The abstracts report associations with expression, cytokines or behavior; none of the cited abstracts reports a lesion-volume or functional-recovery endpoint, so claims that a model "shows neuroprotection" should be read as claims about the specific endpoints listed above. Nothing supports use outside the laboratory. For more, see Selank and Semax compared, the research library and the shop.
Frequently asked questions
Which animal models have been used for Semax?
Rat models of permanent and transient cerebral ischemia, acute spinal cord injury, chronic unpredictable stress, acute restraint stress and neonatal maternal deprivation.
Which model is best for gene expression questions?
Occlusion and restraint-stress models have the most RNA-seq and qPCR data, at 4.5 to 24 hours and from 3 to 72 hours depending on the model.
What was measured in the spinal cord injury model?
IL-4, IL-10 and IL-13 by immunohistochemistry in the posterior horn at 3 and 6 hours after mild or severe clip injury.
Why include a comparator peptide?
Pro-Gly-Pro and ACTH(6-9)PGP show their own expression profiles, so they help separate which part of the sequence is associated with an effect.
Do the abstracts report functional recovery?
Not in the abstracts cited here. They report expression, cytokine and behavioral endpoints.
How do I convert nmol/kg to µg/kg?
Multiply by molar mass in g/mol and divide by 1000. For the Semax formula the molar mass is about 813.9 g/mol.
Why is the route listed per model?
Intranasal, intraperitoneal and other routes appear across papers, and one study found the outcome depends on route, so route is part of the model definition.
Are females included?
Several of the cited studies used males, which limits conclusions about sex.
How should the vial be stored?
At 2–8 °C, or −20 °C for long-term storage, protected from heat, moisture and light, as stated on the product page.
Is this a recommendation for any use?
No. It is a literature guide for laboratory research planning.
Research-use statement
This product is supplied for laboratory research use only. It is not a drug, food or cosmetic, and it is not for human or animal consumption. This article summarizes published animal studies without recommending any application.
Related reading: Semax as a Nootropic Peptide: Reading the Research, Semax Research Peptide: Reference Sheet and Literature Map, Semax Storage and Handling: Methionine Oxidation Focus.
References
- Dmitrieva VG, Povarova OV, Skvortsova VI, Limborska SA, Myasoedov NF, Dergunova LV. Semax and Pro-Gly-Pro Activate the Transcription of Neurotrophins and Their Receptor Genes after Cerebral Ischemia. Cell Mol Neurobiol. 2009;30(1):71-79. doi:10.1007/s10571-009-9432-0
- Filippenkov IB, Remizova JA, Stavchansky VV, Denisova AE, Gubsky LV, Myasoedov NF, et al. Synthetic Adrenocorticotropic Peptides Modulate the Expression Pattern of Immune Genes in Rat Brain following the Early Post-Stroke Period. Genes. 2023;14(7):1382. doi:10.3390/genes14071382
- Filippenkov IB, Shpetko YY, Stavchansky VV, Denisova AE, Gubsky LV, Andreeva LA, et al. ACTH-like Peptides Compensate Rat Brain Gene Expression Profile Disrupted by Ischemia a Day After Experimental Stroke. Biomedicines. 2024;12(12):2830. doi:10.3390/biomedicines12122830
- Asadullah A, Bajamal AH, Parenrengi MA, Turchan A, Utomo B, Sudiana IK, et al. Effect of ACTH4-10Pro8-Gly9-Pro10 on anti-inflammatory cytokine (IL-4, IL-10, IL-13) expression in acute spinal cord injury models (male Sprague Dawley rats). F1000Res. 2025;12:194. doi:10.12688/f1000research.127413.2
- Inozemtseva LS, Yatsenko KA, Glazova NY, Kamensky AA, Myasoedov NF, Levitskaya NG, et al. Antidepressant-like and antistress effects of the ACTH(4–10) synthetic analogs Semax and Melanotan II on male rats in a model of chronic unpredictable stress. European Journal of Pharmacology. 2024;984:177068. doi:10.1016/j.ejphar.2024.177068
- Filippenkov IB, Stavchansky VV, Glazova NY, Sebentsova EA, Remizova JA, Valieva LV, et al. Antistress Action of Melanocortin Derivatives Associated with Correction of Gene Expression Patterns in the Hippocampus of Male Rats Following Acute Stress. IJMS. 2021;22(18):10054. doi:10.3390/ijms221810054
- Volodina MA, Sebentsova EA, Glazova NY, Levitskaya NG, Andreeva LA, Manchenko DM, et al. Semax Attenuates the Infl uence of Neonatal Maternal Deprivation on the Behavior of Adolescent White Rats. Bull Exp Biol Med. 2012;152(5):560-563. doi:10.1007/s10517-012-1574-2
